APAIIF 亞太人工智能產業總會APAIIFAI Knowledge
AI in Healthcare

South Korea KRICT Breakthrough: Human-in-the-Loop AI Scientist Cuts Experiment Time by 75%, LLM Combined with Bayesian Optimization Reshapes Autonomous Labs

October 15, 20264 Views
South Korea KRICT Breakthrough: Human-in-the-Loop AI Scientist Cuts Experiment Time by 75%, LLM Combined with Bayesian Optimization Reshapes Autonomous Labs
AI科學家
自主實驗室
貝葉斯優化
韓國AI研究
化學AI

South Korea KRICT Breakthrough: Human-in-the-Loop AI Scientist Cuts Experiment Time by 75%, LLM Combined with Bayesian Optimization Reshapes Autonomous Labs

On October 14, 2026, South Korea's Korea Research Institute of Chemical Technology (KRICT) announced a major scientific breakthrough that could fundamentally change how autonomous laboratories operate. A team led by senior researcher Ahn Gwangno of the Chemical Platform Research Division developed a "Human-in-the-Loop Optimization" technology that combines large language models (LLMs) with Bayesian optimization, enabling researchers to convey experimental knowledge in natural language to AI systems, dramatically reducing the time required for experiments.

Research Background: The "Starting from Scratch" Problem in Autonomous Labs

Existing autonomous laboratory AI systems typically operate from a "blank slate," meaning they need to "relearn" basic scientific principles through numerous expensive experiments — such as the relationship between temperature and yield, or the effect of solvent selection on reactions. This approach is not only time-consuming but also wastes significant resources.

The KRICT research team identified this core problem: existing systems cannot effectively utilize the experimental knowledge accumulated by researchers over decades. This knowledge often exists in unstructured form in researchers' minds, making it difficult to directly input into traditional optimization algorithms.

Technical Breakthrough: LLM as Knowledge Translator

The KRICT team's solution is elegant and practical: using LLMs as "translators" between researchers and Bayesian optimization algorithms.

How It Works

  1. Natural Language Input: Researchers describe their experimental knowledge and hypotheses in everyday language via speech or text, such as "In this type of reaction, temperatures above 80°C typically lead to increased byproducts"
  2. LLM Interpretation: The large language model converts these natural language descriptions into prior information and constraints that Bayesian optimization algorithms can understand
  3. Optimization Acceleration: The Bayesian optimization algorithm uses this prior knowledge to more intelligently select the next experimental conditions, avoiding wasting experimental resources in known ineffective parameter spaces
  4. AI Co-Scientist Interface: Researchers can dynamically adjust the experimental direction through ongoing dialogue, achieving true human-AI collaboration

Adaptive Reliability Verification

To prevent researchers from providing incorrect guidance, the system has a built-in "Adaptive Reliability Verification" mechanism. If a researcher's input leads to experimental results that deviate significantly from actual data, the system automatically disregards the advice and switches back to pure data-driven exploration mode. This safety mechanism ensures system robustness and prevents human errors from being amplified.

Experimental Validation Results

The research team validated the system in a virtual environment based on real experimental data, with impressive results:

Multi-Feedstock Reaction Scenario

  • Traditional autonomous system: Approximately 30 experimental searches required to achieve target performance
  • KRICT human-in-the-loop system: Number of experiments reduced to fewer than 10
  • Efficiency improvement: More than 66% reduction in experiment count

Electrically Conductive Composite Materials Research Scenario

  • Traditional autonomous system: Approximately 20 experimental searches required
  • KRICT human-in-the-loop system: Number of experiments reduced to 3-5
  • Time reduction: Up to 75%

These numbers mean that experimental cycles that previously took weeks or even months could be shortened to days — revolutionary for fields requiring extensive experimental iteration such as drug development and new materials discovery.

Research Publication

The research findings have been published in the international top-tier journal Journal of Chemical Information and Modeling, with research data based on experiments conducted in July-August 2026. The research team plans to apply this technology to physical autonomous laboratory equipment for further real-world validation.

Impact on Asia-Pacific Scientific Research

KRICT's breakthrough has significant implications for research institutions across the Asia-Pacific region:

Drug Development Acceleration: Pharmaceutical companies in the Asia-Pacific region (including major pharmaceutical companies in Japan, South Korea, China, and India) can use this technology to significantly shorten the screening cycle for new drug candidate compounds, reducing R&D costs.

Materials Science Innovation: For research in semiconductor materials, battery materials, polymer materials, and other fields, the human-AI collaborative scientist can significantly accelerate the discovery and optimization of new materials.

Research Resource Optimization: With limited research funding, reducing experiments by 75% means the same budget can explore a wider range of research directions, improving the return on research investment.

Knowledge Transfer: This technology also helps address the problem of scientific knowledge transfer — the tacit knowledge of senior researchers can be systematically integrated into the AI optimization process through natural language input.

Comparison with Global AI Scientist Trends

KRICT's research aligns closely with global trends in AI applications for scientific research. In 2026, multiple top research institutions and technology companies are actively exploring AI in scientific research:

  • Google DeepMind: Continued breakthroughs in protein structure prediction with the AlphaFold series
  • Microsoft Research: AI-assisted mathematical proof and scientific hypothesis generation
  • Insilico Medicine: AI-driven drug molecule design (already signed a $2.75 billion partnership with Eli Lilly)

KRICT's unique contribution lies in its emphasis on "human-AI collaboration" rather than fully autonomous AI systems. This approach acknowledges the irreplaceable nature of human expertise while fully leveraging AI's advantages in optimization and search.

Future Outlook

The research team stated that the next step is to apply this technology to physical autonomous laboratory equipment for validation in real chemical laboratory environments. If physical validation is successful, this technology is expected to be commercialized within 2-3 years, providing more efficient experimental optimization tools for research institutions worldwide.

Conclusion

KRICT's human-in-the-loop AI scientist breakthrough represents an important advance in autonomous laboratory technology. By using LLMs as bridges between researcher knowledge and Bayesian optimization algorithms, this technology not only significantly improves experimental efficiency but, more importantly, finds a way to organically combine human expertise with AI capabilities. For research institutions in the Asia-Pacific region, this breakthrough provides an important opportunity to accelerate scientific innovation and enhance competitiveness.

FAQ

Related Articles

Aidoc AI Radiology Foundation Model: 2,000 Hospitals, 60 Million Annual Cases, FDA Clearance for 14 CT Triage Conditions, Radiology AI Enters Scale Era
AI in Healthcare

Aidoc AI Radiology Foundation Model: 2,000 Hospitals, 60 Million Annual Cases, FDA Clearance for 14 CT Triage Conditions, Radiology AI Enters Scale Era

Aidoc's AI radiology platform covers nearly 2,000 hospitals processing 60 million annual cases, receiving FDA clearance in January 2026 for a foundation model CT triage solution covering 14 clinical conditions. Radiology AI accounts for 76% of all FDA AI medical device clearances as the industry enters a new era of scaled deployment.

Nov 2, 202612
AI Ambient Scribe Clinical Evidence: 2.3 Million Encounters Show 31% Physician Burnout Reduction, 2x ROI in 14 Months
AI in Healthcare

AI Ambient Scribe Clinical Evidence: 2.3 Million Encounters Show 31% Physician Burnout Reduction, 2x ROI in 14 Months

Multiple large-scale 2026 clinical studies confirm AI ambient scribe benefits: 2.3 million encounter data shows physician burnout dropping from 51.9% to 38.8% (31% reduction), 13-16 minutes saved per shift, 87-89% semantic accuracy, and 2x+ ROI within 14 months, though research notes time savings are often reinvested into patient interaction rather than reduced work hours.

Nov 1, 202614
Stanford SIMCO AI Framework Breakthrough: Aspirin-Lansoprazole Combination 15× More Effective Than Aspirin Alone for Preterm Birth Prevention, Now in Clinical Trial
AI in Healthcare

Stanford SIMCO AI Framework Breakthrough: Aspirin-Lansoprazole Combination 15× More Effective Than Aspirin Alone for Preterm Birth Prevention, Now in Clinical Trial

Stanford's SIMCO AI framework, simulating 218 million immune cells, discovered that the aspirin-lansoprazole (SALPZ) combination is 15× more effective than aspirin alone at preventing preterm birth, with a median 17.3-day labor delay and 87.3% responder rate. FDA has authorized a 670-patient clinical trial.

Oct 31, 202611